FDA Approves Bayer’s Kerendia for Chronic Kidney D...
Category : Approval/Launch 22 September 2026Bayer has announced that the U.S. Food and Drug Administration (FDA) has approved Kerendia (finereno...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Merry Life Biomedical Advances TML-6 Into Global P...
Category : Clinical Trial Update 22 September 2026Merry Life Biomedical has announced that TML-6, an investigational oral treatment developed in Taiwa...
Quotient Sciences Uses AI Algorithm to Select Modi...
Category : Clinical Trial Update 18 September 2026AI Algorithm Reaches Pharmacokinetic Target Within Three Dosing Periods Quotient Sciences has rep...
Biogen Publishes Adolescent Data From Phase 3 VALI...
Category : Clinical Trial Update 18 September 2026Study Results Show Reduced Proteinuria in Adolescents With Rare Kidney Diseases Biogen Inc. has a...
Sanofi and Cheplapharm Plan Strategic Partnership...
Category : Licensing/Collaboration Deal 17 September 2026Cheplapharm to Take Over Selected Medicines and Three Manufacturing Sites Sanofi and Cheplapharm...
Latest Newsletter Post
-
Merry Life Biomedical Advances TML-..
22 September 2026
-
FDA Approves Bayer’s Kerendia for C..
22 September 2026
-
Biogen Publishes Adolescent Data Fr..
18 September 2026
-
Quotient Sciences Uses AI Algorithm..
18 September 2026
-
FDA Accepts Takeda’s Zasocitinib Ap..
17 September 2026
